BR112021024138A2 - Sistema para administração supervisionada eletronicamente de uma composição farmacêutica - Google Patents

Sistema para administração supervisionada eletronicamente de uma composição farmacêutica

Info

Publication number
BR112021024138A2
BR112021024138A2 BR112021024138A BR112021024138A BR112021024138A2 BR 112021024138 A2 BR112021024138 A2 BR 112021024138A2 BR 112021024138 A BR112021024138 A BR 112021024138A BR 112021024138 A BR112021024138 A BR 112021024138A BR 112021024138 A2 BR112021024138 A2 BR 112021024138A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
administration
authorized entity
electronically
patient
Prior art date
Application number
BR112021024138A
Other languages
English (en)
Inventor
Artur Wieczorek
Ewa Tratkiewicz
Maciej Majstruk
Maciej Wieczorek
Original Assignee
Celon Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celon Pharma Sa filed Critical Celon Pharma Sa
Publication of BR112021024138A2 publication Critical patent/BR112021024138A2/pt

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L63/00—Network architectures or network communication protocols for network security
    • H04L63/08—Network architectures or network communication protocols for network security for authentication of entities
    • H04L63/0853—Network architectures or network communication protocols for network security for authentication of entities using an additional device, e.g. smartcard, SIM or a different communication terminal
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L9/00—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols
    • H04L9/32—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols including means for verifying the identity or authority of a user of the system or for message authentication, e.g. authorization, entity authentication, data integrity or data verification, non-repudiation, key authentication or verification of credentials
    • H04L9/321—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols including means for verifying the identity or authority of a user of the system or for message authentication, e.g. authorization, entity authentication, data integrity or data verification, non-repudiation, key authentication or verification of credentials involving a third party or a trusted authority
    • H04L9/3213—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols including means for verifying the identity or authority of a user of the system or for message authentication, e.g. authorization, entity authentication, data integrity or data verification, non-repudiation, key authentication or verification of credentials involving a third party or a trusted authority using tickets or tokens, e.g. Kerberos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Computer Security & Cryptography (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Computing Systems (AREA)
  • General Engineering & Computer Science (AREA)
  • Computer Hardware Design (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Mobile Radio Communication Systems (AREA)

Abstract

sistema para administração supervisionada eletronicamente de uma composição farmacêutica. sistema para administração supervisionada eletronicamente de uma composição farmacêutica, que compreende um nó de entidade autorizada (100, 200) para uma entidade autorizada, um dispositivo móvel (300) de um paciente, e um dispositivo médico (400) adaptado para administrar a composição farmacêutica, sendo que o nó de entidade autorizada (100, 200) é adaptado, quando operado pela entidade autorizada, para gerar dados correspondendo a um esquema de administração (11) e um token de autorização (12) para atribuir a um dispositivo móvel de paciente (300), e para enviar os dados correspondendo a um esquema de administração (11) e token de autorização (12) para o dispositivo móvel de paciente (300).
BR112021024138A 2019-05-31 2019-05-31 Sistema para administração supervisionada eletronicamente de uma composição farmacêutica BR112021024138A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2019/064243 WO2020239243A1 (en) 2019-05-31 2019-05-31 Electronically supervised administration of a pharmaceutical composition

Publications (1)

Publication Number Publication Date
BR112021024138A2 true BR112021024138A2 (pt) 2022-01-11

Family

ID=66998338

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021024138A BR112021024138A2 (pt) 2019-05-31 2019-05-31 Sistema para administração supervisionada eletronicamente de uma composição farmacêutica

Country Status (9)

Country Link
US (1) US20220230723A1 (pt)
EP (1) EP3977469A1 (pt)
JP (1) JP2022542746A (pt)
KR (1) KR20220012922A (pt)
CN (1) CN113906517A (pt)
AU (1) AU2019447630A1 (pt)
BR (1) BR112021024138A2 (pt)
CA (1) CA3140088A1 (pt)
WO (1) WO2020239243A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102473239B1 (ko) * 2019-09-02 2022-12-01 (주)인트인 공기질 정보를 이용하여 호흡기 치료 정보를 제공하는 건강 관리 시스템 및 건강 관리 서버
US11382873B1 (en) * 2021-01-08 2022-07-12 Vitalis Analgesics LLC Oral administration of ketamine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003511760A (ja) * 1999-10-01 2003-03-25 グラクソ グループ リミテッド 患者データ監視システム
US20100100237A1 (en) 2004-12-11 2010-04-22 Novation Science Holding, Llc Smart Medicine Container
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8785500B2 (en) 2006-03-22 2014-07-22 Icahn School Of Medicine At Mount Sinai Intranasal administration of ketamine to treat depression
US8579853B2 (en) * 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
DE102007009888A1 (de) 2007-02-28 2008-09-04 Hermann, Holger Lars, Dr. Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen
US9235689B2 (en) 2007-03-13 2016-01-12 Medicasafe, Inc. Method, system and apparatus for controlling patient access to medicaments
WO2013138322A1 (en) 2012-03-12 2013-09-19 Janssen Pharmaceutica Nv Esketamine for the treatment of treatment-refractory or treatment-resistant depression
US20140079740A1 (en) 2012-08-02 2014-03-20 ClinPharm Support GmbH Oral transmucosal adminstration forms of s-ketamine
WO2014152196A1 (en) 2013-03-15 2014-09-25 Janssen Pharmaceutica Nv Pharmaceutical composition of s-ketamine hydrochloride
CN105073103A (zh) 2013-03-15 2015-11-18 詹森药业有限公司 S-盐酸氯胺酮的药物组合物
US20140297028A1 (en) 2013-03-29 2014-10-02 Edward J. Bilotti Device for dispensing medication used for office-based opiate dependence treatment
EP3151906B1 (en) * 2014-06-03 2019-12-11 Pop Test Abuse Deterrent Technology LLC Drug device configured for wireless communication
GB201418350D0 (en) * 2014-10-16 2014-12-03 Elucid Mhealth Ltd Dispenser and methods of use thereof
EP3596635A1 (en) * 2017-03-15 2020-01-22 Novartis AG System for administering a pharmaceutical product
EP3672559B1 (en) 2017-08-25 2022-03-09 Barbosa de Abreu e Sousa, Armando Miguel Medicament dispenser

Also Published As

Publication number Publication date
AU2019447630A1 (en) 2021-12-23
KR20220012922A (ko) 2022-02-04
CN113906517A (zh) 2022-01-07
US20220230723A1 (en) 2022-07-21
CA3140088A1 (en) 2020-12-03
JP2022542746A (ja) 2022-10-07
EP3977469A1 (en) 2022-04-06
WO2020239243A1 (en) 2020-12-03

Similar Documents

Publication Publication Date Title
BR112018077021A2 (pt) terapias de combinação
BR112016002465A2 (pt) terapia da combinação para o tratamento de câncer
BR112019006808A2 (pt) método e sistema para controlar e monitorar remotamente um dispositivo eletrônico, e, meio legível por computador tangível não transitório.
BR112016006188A2 (pt) método de tratamento com um protocolo de fármaco e um sistema com uma base de dados relacional acoplado a um ou mais dispositivos eletrônicos ; sistema para a gestão de um tratamento medicamentoso pela administração de um fármaco a um paciente e método de gestão de um tratamento com drogas usando um sistema de informação com uma base de dados relacional.
WO2015176062A3 (en) Systems and methods of managing treatment of a chronic condition by symptom tracking
BR112017014209A2 (pt) design de aparelhos dentários auxiliado por sistema de computador
BR112015024300A2 (pt) sistema de planejamento de terapia para tratamento de um alvo interno de um paciente, método de aplicação de terapia para tratamento de um alvo interno de um paciente, um ou mais processadores programados para controlar o tratamento de uma parte interna de um paciente, mídia legível por computador não temporária, e sistema de aplicação de terapia para tratamento de um alvo interno de um paciente
BR112016024472A2 (pt) composto, medicamento, métodos para modulação alostérica positiva e para profilaxia ou tratamento de doenças, e, uso de um composto
BR112012019101A2 (pt) módulo medicamentoso com botão de uso duplo e sistema de fornecimento de medicamento.
EA201690069A1 (ru) Применение высоких доз придопидина для лечения болезни хантингтона
BR112021024138A2 (pt) Sistema para administração supervisionada eletronicamente de uma composição farmacêutica
BR112013001629A8 (pt) seringa de câmara dupla com agulha retrátil
BR112017003186A2 (pt) composição farmacêutica para tratamento de cancer positivo para mutação em flt3, inibidor de flt3 mutante e usos dos mesmos
AR089862A1 (es) USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA
BR112022005667A2 (pt) Interconexão de sistema de administração de fármaco
BR112016027435A2 (pt) formulação inovadora de meloxicam
CL2016001794A1 (es) Metodo para administrar tasimelteon a un paciente humano que incluye la administración oral de una dosis efectiva en condiciones de ayuno para tratar un trastorno del ritmo circadiano o un trastorno del sueño, como el trastorno del sueño-vigilia diferente a 24 horas no-24 metodo para acortar el tmax del tasimelteon en un paciente humano que está siendo tratado con tasimelteon.
BR112017006272A2 (pt) composição farmacêutica para tratar colite ulcerativa.
BR122021000189A8 (pt) Ferramenta, sistema e método ex vivo para monitoramento de fármaco
NZ769954A (en) Syringe devices for use in an emergency
CY1120871T1 (el) Αποστειρωμενη ευκαμπτη συσκευασια για την ανασυσταση και χορηγηση υγρων φαρμακευτικων ή θρεπτικων ουσιων οι οποιες εγχυονται ή ενσταλαζονται εντος του σωματος ενος ασθενους και διαδικασια για την αποστειρωση αυτης
BR112019022401A2 (pt) identificador de dispositivo único implantável e sistema de detecção
BR112022005648A2 (pt) Sistema de administração de fármacos configurado para determinar um esquema de dosagem de fármacos
MA39447B1 (fr) Pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine
BR112019002655A2 (pt) composto, intermediário de síntese, uso e composição farmacêutica neuromoduladora